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Introduction: To stimulate healing of large bone defects research has concentrated on the application of
mesenchymal stem cells (MSCs).
Methods: In the present study, we induced the overexpression of the growth factors bone morphogenetic protein
2 (BMP-2) and/or Indian hedgehog (IHH) in human MSCs by adenoviral transduction to increase their osteogenic
potential. GFP and nontransduced MSCs served as controls. The influence of the respective genetic modification on
cell metabolic activity, proliferation, alkaline phosphatase (ALP) activity, mineralization in cell culture, and osteogenic
marker gene expression was investigated.
Results: Transduction had no negative influence on cell metabolic activity or proliferation. ALP activity showed a
typical rise-and-fall pattern with a maximal activity at day 14 and 21 after osteogenic induction. Enzyme activity
was significantly higher in groups cultured with osteogenic media. The overexpression of BMP-2 and especially IHH
+ BMP-2 resulted in a significantly higher mineralization after 28 days. This was in line with obtained quantitative
reverse transcriptase polymerase chain reaction (qRT-PCR) analyses, which showed a significant increase in
osteopontin and osteocalcin expression for osteogenically induced BMP-2 and IHH + BMP-2 transduced cells when
compared with the other groups. Moreover, an increase in runx2 expression was observed in all osteogenic
groups toward day 21. It was again more pronounced for BMP-2 and IHH + BMP-2 transduced cells cultured in
osteogenic media.
Conclusions: In summary, viral transduction did not negatively influence cell metabolic activity and proliferation.
The overexpression of BMP-2 in combination with or without IHH resulted in an increased deposition of
mineralized extracellular matrix, and expression of osteogenic marker genes. Viral transduction therefore represents
a promising means to increase the osteogenic potential of MSCs and the combination of different transgenes may
result in synergistic effects.* Correspondence: johannes.c.reichert@gmail.com
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The majority of bone defects and fractures show spon-
taneous healing, stimulated by well-orchestrated en-
dogenous cell populations and microenvironmental cues.
Generally, treatment outcomes have improved because
of advances regarding surgical techniques and implant
design. However, different factors, such as biomechanical
instability and extensive soft tissue trauma, can ultim-
ately promote the formation of nonunions and defects
characterized by a restricted regenerative potential [1].
Such bone defects are associated with considerable sur-
gical challenges and have a high socioeconomic impact,
greatly curtailing affected patients’ quality of life [2,3].
The augmentation of large bone defects usually requires
the application of autologous bone graft (ABG). Limiting
associated factors include graft availability, comorbidity,
and insufficient bony integration.
Research in the field has therefore concentrated on the
application of mesenchymal stem cells (MSCs), which
are able to differentiate into bone-forming osteoblasts
[4]. Successful translation of tissue engineering concepts
to the field of oral and maxillofacial surgery has sug-
gested the extension to long bone regeneration [5,6].
However, promising results obtained in vitro or in small
animal models could seldom be reproduced in the hu-
man organism [7].
In the present study, we therefore induced the over-
expression of the growth factors bone morphogenetic
protein 2 (BMP-2) and/or Indian hedgehog (IHH) in hu-
man MSCs by adenoviral transduction to increase their
osteogenic potential.
The beneficial effects of BMP-2 on osteogenic dif-
ferentiation are well documented [8]. The hedgehog
pathway plays a critical role in skeletogenesis, control-
ling self-renewal, migration, differentiation, and cell-fate
commitment of embryonic as well as adult stem or pro-
genitor cells [9]. All hedgehog proteins consist of a sig-
nal peptide, with a well-conserved N-terminal region
serving the role of a signaling peptide. Hedgehog signal
transduction is mediated by Smoothened (Smo), a G
protein-coupled receptor with specificity toward Gi pro-
teins [10]. Hedgehog-targeted cells present two compo-
nents of the hedgehog-receptor complex on the cell
surface: Smoothened (Smo) and Patched (Ptc). Ptc re-
presses the activity of Smo, which regulates proteolytic
processing of downstream zinc-finger transcription fac-
tors Gli1, 2, and 3. Although Gli2 rather seems to func-
tion as an activator, Gli3 acts mainly as a repressor [11].
We therefore hypothesized that MSCs overexpressing
BMP-2 and/or IHH represent a powerful tool with a su-
perior regenerative potential to native MSC. BMP trans-
duction was chosen, as de novo bone formation in vivo
is partly attributed to members of the transforming
growth factor-β (TGF-β) superfamily, specifically thebone morphogenetic proteins (BMPs) [12] that were
shown to have clinical utility in the treatment of recalci-
trant nonunions [13] or spinal fusion [14] when deliv-
ered as recombinant proteins. The hedgehog pathway
conversely plays a critical role in skeletogenesis that im-
plicates mesenchymal precursors [15,16].
Materials and methods
MSC isolation and culture
Human MSCs were isolated as described previously [17].
After informed consent, freshly reamed trabecular bone
from the acetabulum of patients undergoing total hip
arthroplasty was transferred to 50 ml conical tubes
(Greiner Bio-One, Frickenhausen, Germany) containing
Dulbecco’s Modified Eagle Medium (DMEM; PAA La-
boratories, Linz, Austria) supplemented with 10% fetal
bovine serum (FBS; PAA) and antibiotics (50 IU penicil-
lin/ml and 50 μg streptomycin/ml, PAA). The tubes
were vortexed to disperse the marrow cells from the
bone plugs. After centrifugation to high density pellets
the released cells could be collected. The extracted cells
were counted with a haemocytometer and plated at a
density of 3 × 106 cells per 175 cm2 tissue culture flask
(Greiner Bio-One, Frickenhausen, Germany). After 2 days
of culture, non-adherent cells were removed and the at-
tached cells were washed twice with phosphate buffered
saline (PBS). Cells were subsequently plated at a density
of 3000/cm2 and expanded to the second or third pas-
sage for further experiments.
The study was approved by the institutional review
board of the University of Würzburg in Germany.
Generation and propagation of recombinant adenoviral
vectors
First-generation, E1-, E3-deleted, serotype 5 adenoviral
vectors carrying the cDNAs for human IHH, BMP-2, or
green fluorescent protein (GFP) were constructed by
using cre-lox recombination, as described previously
[18,19]. The resulting vectors were designated Ad.IHH,
Ad.BMP-2, and Ad.GFP. The vectors were propagated
by amplification in 293/Cre8 cells and purified over
cesium chloride gradients. After dialysis against 10 mM
Tris-hydrochloric acid, pH 7.8, 150 mM sodium chlo-
ride, 10 mM magnesium chloride, and 4% sucrose, viral
titers were estimated to be between 1010 and 1011 infec-
tious viral particles (ip)/ml, as assessed by optical density
measurements and a standard plaque assay.
Transduction of MSC cultures and transgene expression
At confluence, MSC cultures were infected in 4 ml/
175 cm2 of serum-free DMEM for 3 hours with 50 ip/cell
of Ad.IHH, Ad.BMP-2, or in combination. Control
cultures were similarly infected with similar doses of
Ad.GFP or remained uninfected. After viral infection,
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20 ml of complete DMEM.
Media conditioned over a period of 24 hours were
collected at several time points and assayed for IHH
(Cusabio Biotech, Newark, DE, USA) and BMP-2 (R&D
Systems) by using commercially available ELISA kits.
Cell-proliferation assay
Adherent passage 3 MSCs were seeded in triplicate at
3,000 per square centimeter in flat-bottomed 24-well
plates and maintained in 1-ml standard culture medium,
consisting of DMEM supplemented with 10% FBS for 1,
3, 5, or 7 days in a humidified atmosphere (37°C, 5%
CO2). At each time point, cells were washed twice with
PBS and stored at −80°C until analysis. For analysis,
samples were digested overnight with 0.5 mg/ml pro-
teinase K in 1 × Tris-EDTA buffer at 55°C. DNA content
for 100 μl of each sample in triplicate was measured and
quantified by using a Qubit dsDNA BR assay kit,
according to the protocol supplied by the manufacturer
(Invitrogen). Fluorescence was measured at an excitation
wavelength of 485 nm and an emission wavelength of
530 nm.
Cell metabolic activity
Each cell type was seeded at a density of 3 × 103 cells/cm2
in 100 μl culture media (phenol red free) in triplicate onto
black 96-well plates and cultured for 4, 24, 48, 72, and
96 hours without media change. Two hours before the
assay, 10 μl of AlamarBlue reagent (DAL1025; Biosource,
Camarillo, CA, USA) were added to the culture medium
at a final concentration of 10% (vol/vol). AlamarBlue
added to medium served only as a negative control. Fluor-
escent signals (excitation 540 nm, emission 600 nm) were
detected by using a fluorescence plate reader.
Osteogenic induction of MSC cultures
Human MSCs were seeded at a density of 3,000 cells/
cm2 into six-well polystyrene tissue-culture plates. After
reaching confluence, mineralization was induced by sup-
plementing the culture media with 50 μg/ml ascorbate-2-
phosphate (Sigma-Aldrich), 10 mM β-glycerophosphate
(Sigma-Aldrich), and 0.1 μM dexamethasone (Sigma-Al-
drich) over a period of 28 days. Controls were cultured in
normal culture medium. Media were changed every 3 days.
Alkaline phosphatase activity
Cultures were washed and incubated with 1 ml phenol
red- and serum-free DMEM for 24 hours. Then 100 μl
media supernatant was transferred in triplicate to a
96-well plate (Nunc). After 3 hours of incubation with
100 μl p-nitrophenylphosphate/0.2M Tris buffer at a
concentration of 1 mg/ml (Sigma), optical density at
405 nm was measured. ALP activity was normalizedagainst the sample DNA content, determined by using a
Qubit dsDNA BR assay kit (Invitrogen).
Alizarin red S
Cultures were washed twice with double-distilled water
(ddH2O), fixed with ice-cold methanol for 10 minutes,
and incubated with 1% alizarin red S (Sigma-Aldrich) in
ddH2O, pH 4.1, for 10 minutes at room temperature.
After removal of the unincorporated dye, samples were
washed at least 3 times with ddH2O and air-dried.
Images of stained monolayers were captured with
inverted-phase microscopy. The staining was quanti-
fied as described previously [20].
Calcium assay
After 28 days, 2D cultures were washed with ddH2O
and incubated with 800 μl of 10% acetic acid for
30 minutes at RT. Samples were heated to 85°C for
10 minutes, followed by a 10-minute incubation step
on ice. Then 200 μl of 10% ammonium hydroxide
was added to 500 μl of each sample. Triplicate 10-μl
aliquots were transferred into a 96-well plate, to which
100 μl of a mono-ethanolamine buffer, pH 11.0, was
added for a 3-minute incubation at 37°C, followed by
100 μl of o-cresolphthalein complexion (Calcium O-
Cresolphthalein Kit; MTI Diagnostics, Wiesbaden,
Germany) and incubation for 5 minutes at 37°C. To
generate a standard curve, a standard dilution series in
10% acetic acid was used. Measurements were taken at
λ = 570 nm.
RNA isolation, primer design, and qRT-PCR
Total RNA was harvested in triplicate from control as
well as differentiated samples at days 0, 7, 14, 21, and
28. Samples were isolated by using the NucleoSpin RNA
II Kit (Machery-Nagel) according to the manufacturer’s
instructions. cDNA was synthesized from 1 μg of total
RNA by using the SuperScript III kit (Invitrogen). Quan-
titative RT-PCR for alkaline phosphatase, osteopontin
(OP), osteocalcin (OC), and runx2 was performed as de-
scribed previously (Table 1) [20].
Statistical analysis
Statistical analysis was performed by using ANOVA
(IBM SPSS 19.0), and p values < 0.05 were considered
significant.
Results
Viral transduction of primary human MSCs with Ad.
IHH, Ad.BMP-2, Ad.GFP or Ad.IHH, and Ad.BMP-2 in
combination led to a slight but nonsignificant decrease
in metabolic activity over the first 72 hours after trans-
duction (Figure 1a). Genetic modification by viral trans-
duction did not negatively affect cell proliferation. All
Table 1 qRT-PCR primer sequences
Gene Sequence (5′-3′; F, forward;, R, reverse) Product (bp)
ALP F – GTACGAGCTGAACAGGAACAACG 151
R – CTTGGCTTTTCCTTCATGGTG
OP F – TATGATGGCCGAGGTGATAG 133
R – CATTCAACTCCTCGCTTTCC
OC F – TGACCACATCGGCTTTCAG 126
R – AAGGGGAAGAGGAAAGAAGG
Runx2 F – CTTCACAAATCCTCCCCAAG 147
R – ATGCGCCCTAAATCACTGAG
RPS27A F – TCGTGGTGGTGCTAAGAAAA 141
R – TCTCGACGAAGGCGACTAAT
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native nonmodified primary MSCs, and no significant
differences were observed between groups. Neverthe-
less, a tendency toward an increased proliferative cap-
acity was observed after BMP-2 or IHH transduction
(Figure 1b).
Monolayer cultures infected with Ad.IHH, Ad.BMP-2,
Ad.GFP or Ad.IHH, and Ad.BMP-2 in combination at
50 ip/cell generated high levels of transgene products at
day 7 of culture, with doses ranging from 130 to
160 pg/ml for BMP-2 and 160 to 250 pg/ml for IHH.
The amount of transgene declined over time, as evi-
denced by ELISA measurements (Figure 1c and d).
Induction with osteogenic media caused an increase of
alkaline phosphatase (ALP) activity in all groups when
compared with control cultures. The level of enzyme ac-
tivity displayed a typical increase-and-decrease pattern.
ALP activity appeared to be significantly higher on day
21 in BMP-transduced cells and cells transduced withFigure 1 Metabolic activity, proliferation, and levels of transgene pro
proliferation behavior (b) of native mesenchymal progenitor cells (Ctrl) and
IHH, as determined with AlamarBlue and Quibit assays. Furthermore, the le
ELISA, are demonstrated. The asterisks indicate statistically significant differeBMP-2 and IHH in combination, when compared with
native MSCs (Figure 2a and b). A statistically significant
difference between the BMP and BMP + IHH groups,
however, could not be determined.
Compared with controls, osteogenic induction fur-
thermore increased the deposition of mineralized extra-
cellular matrix, which started around day 14 of culture.
Mineralization was accelerated in monolayers trans-
duced with BMP-2 and IHH in combination, when com-
pared with all other groups, to result in a significantly
higher mineralization on day 21. Similar levels of mi-
neralization were observed in osteogenic cultures of
BMP- and BMP + IHH- overexpressing cells on day 28.
These levels of mineralized matrix deposition were mea-
sured to be significantly higher than those in the other
experimental groups (Figure 2c and d, Figure 3). The
quantification of the incorporated alizarin red dye corre-
lated very well with the results of the calcium assay,
measuring calcium amounts ranging from 0.025 to
0.21 mg/six wells (Figure 2e and f).
ALP activity measured on days 0, 7, 14, and 28
displayed a typical increase/decrease pattern significantly
increasing toward day 21 in osteogenically induced
MSCs (P < 0.05) when compared with initial levels on
day 0. On the day of maximum ALP expression (day 21),
no significant differences were observed between the
osteogenic groups. ALP expression in the respective
noninduced controls remained on basal levels (Figure 4a
and b).
OP and OC both showed a significant increase in ex-
pression over time for all groups cultured in osteogenic
media compared with day 0 and cultures in control
media. On day 28, a significantly higher expression was
observed for both genes in the groups transduced withducts. The figure illustrates the cell metabolic activity (a) and
after adenoviral transduction with GFP, BMP-2, IHH, and BMP-2 with
vels of BMP-2 (c) and IHH transgene products (d), determined with
nces compared with control cultures.
Figure 2 ALP activity and mineralization. The figure shows the alkaline phosphatase activity of osteogenic (a) and control (b) monolayer
cultures of native (Ctrl) and transduced mesenchymal progenitor cells. Moreover, the extracellular matrix mineralization of osteogenically induced
(c, e) and control cultures (d, f) over time is depicted. Asterisks indicate statistical significance.
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sion was determined for cells simultaneously overex-
pressing BMP-2 and IHH (Figure 4c through f).
As with ALP, runx2 showed a significantly increasing
expression pattern up to day 21 in osteogenic cultures to
decrease further toward day 28. The expression of the
transcription factor on day 21 was significantly higher in
the BMP-2 and BMP-2 + IHH groups. In noninduced
controls, runx2 expression remained on basal levels
(Figure 4g and h).
Discussion
Sufficient bone healing is strongly dependent on the effi-
cient and coordinated migration, proliferation, and dif-
ferentiation of mesenchymal progenitor cells at the site
of injury. Well-orchestrated molecular pathways pre-
cisely control this process. Hedgehog signaling is known
to contribute to regulate tissue self-renewal processes,
and the migration, differentiation, and cell-fate commit-
ment of embryonic as well as adult stem or progenitor
cells [16].After binding their cell-surface receptors patched-1
and smoothened, hedgehog signal transduction occurs
via members of the Gli family of zinc-finger transcrip-
tion factors (Gli1, 2, and 3) [21]. The hedgehog pathway
was previously reported to be involved in skeletal mor-
phogenesis [15]. It could be demonstrated that IHH-null
mouse embryos lack the typical perichondral expression
of osteogenic markers such as runx2, collagen type I,
and ALP [22]. It was therefore suggested that IHH sig-
naling influences early osteoblastogenesis by modulation
of runx2.
In the present study, we investigated whether adeno-
viral delivery of Indian hedgehog (IHH) is suitable to
increase the osteogenic potential adult human mesen-
chymal progenitor cells. Our results indicate that with
our specific experimental settings, IHH alone fails to do
so, as (when compared with controls), no increased
mineralization was observed in osteogenically induced
MSC cultures transduced with IHH. However, when
combined with simultaneous adenoviral BMP-2 trans-
duction, IHH appeared to accelerate mineralization and
Figure 3 Monolayer mineralization. Alizarin red S stainings on days 14 and 21 of monolayer cultures transduced with GFP, BMP-2, IHH, and
BMP-2 with IHH maintained with osteogenic (left panel) and control (right panel) media. Nonmodified mesenchymal progenitor cells (Ctrl) served
as controls. Magnification, ×10.
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osteopontin and osteocalcin. Both mineralization and
marker expression were greater than the sum of effects
observed in cultures transduced solely with BMP-2 or
IHH. Consequently, IHH and BMP-2 seemed to act
synergistically.
Bone morphogenetic proteins are well-studied mem-
bers of the TGF-β superfamily. Among several of their
functions, BMPs induce the formation of both bone and
cartilage by stimulating the cellular events of mesenchy-
mal progenitor cells [23]. However, only a subset of
BMPs, specifically BMP-2, -4, -7, and -9, have os-
teoinductive activity [8].
As mentioned earlier, in conjunction with BMP-2,
IHH appears to have a synergistic effect on osteogenesis
in the mesenchymal cell type used in our study. Con-
versely, sonic hedgehog (SHH)-induced osteoblasticdifferentiation seems to require functional BMP sig-
naling [24]. Consequently, hedgehog (HH) proteins
and BMP-2 were shown to induce ALP activity syner-
gistically in KS483 cells [25]. Moreover, both IHH
and SHH treatment were shown to stimulate ALP activity
synergistically with BMP-2 in C3H10T1/2 cells and
MC3T3-E1 cells [26]. Similarly, recombinant N-terminal
SHH could cause a greater number of cells to respond to
BMP-2, increasing ALP activity, as demonstrated in
C3H10T1/2, ST2, and primary mouse calvaria cells [24].
ALP is considered a marker for osteoblastic activity
in vitro. ALP activity usually displays a typical increase/de-
crease pattern [27], which is in line with our findings.
It was also reported that hedgehog influence might
depend on the extent of terminal cell differentiation.
Rather, committed osteogenic lineages, such as preosteo-
blastic MC3T3-E1 cells and osteoblastic cell lines, did
Figure 4 RT-PCR analysis. Outcomes of the qRT-PCR measurements for the osteogenic marker genes alkaline phosphatase (ALP (a)),
osteopontin (OP, (b)), osteocalcin (OC, (c)), and runx2 (d) in osteogenic (left panel) and control cultures (right panels).
Reichert et al. Stem Cell Research & Therapy 2013, 4:105 Page 7 of 9
http://stemcellres.com/content/4/5/105not respond to SHH in the presence of BMP-2.
C3H10T1/2 cells that display pluripotent characteris-
tics, conversely did show a response [24]. Conse-
quently, the contribution of HH to osteoblastogenesis
appears of greater importance in the early stages of
differentiation. This may have contributed to the posi-
tive effects observed in our study, in which undiffer-
entiated, multipotent MSCs were used. Study reports
describing mouse perichondrial osteoblastic progeni-
tors to undergo chondrogenesis rather than osteo-
blastogenesis in absence of IHH signaling [28] further
support this hypothesis.Notably, all HH proteins consist of a signal peptide
with a highly conserved N-terminal region. As a result,
HH ligands are functionally interchangeable [21], and
observations made for SHH can most likely be trans-
ferred to IHH.
The literature suggests that the effect of HH on osteo-
blast differentiation, with or without BMP, may differ be-
tween species. HH, in synergy with BMP, appears to
promote osteoblastogenesis in mice, nonsynergistic or
even antagonistic effects may occur in other species. In a
rat model, SHH enhanced endochondral ossification
mediated by runx2, but no increase in ossification was
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eously administered [29]. In human adipose-derived
stem cells, SHH even inhibited osteogenesis, as mea-
sured by decreased ALP and runx2 expression [30].
Runx2, also referred to as core-binding factor subunit
alpha-1 (CBF-α-1), is considered a master gene for os-
teoblast differentiation, matrix production, and mine-
ralization during bone formation. In our study, runx2
was significantly upregulated through the synergistic ef-
fects of BMP-2 and IHH transduction. Runx2 expression
is necessary to achieve differentiation and activation of
osteoblasts. Its null mutation in mice exhibits the
complete absence of bone [31]. Runx2 expression is up-
regulated in proliferative chondrocytes, and it is ex-
pressed early in osteoblastic differentiation. Multiple
signal-transduction pathways can stimulate runx2 gene
expression [32]. Runx2, conversely, can directly control
the expression of essential bone-associated extracellular
matrix protein genes mediated by a direct binding site
(osteoblast-specific cis-acting element (OSE2)). OSE2 can
be found in the promoter region of various osteoblast-
specific genes, such as OC, OP, BSP, and collagen type I
[33,34].
The noncollagenous extracellular matrix components,
such as OC and OP, contribute to provide bone with its
physical and chemical properties [35]. OC is partly in-
corporated into the bone matrix, partly delivered to the
circulatory system, and considered a late and specific
osteogenic marker determining terminal osteoblast dif-
ferentiation regulating bone crystal formation [36]. We
observed a significantly higher OC expression on day 28
after the combined adenoviral transduction of BMP-2
and IHH.
OP is yet another key modulator of bone function. In
our cell-culture experiments, the simultaneous action of
BMP-2 and IHH resulted in a significant upregulation of
OP expression. OP is considered an early osteogenic
marker with affinity for calcium and binding sites for in-
tegrin receptors through a RGD motif. OP, therefore,
functions as an important protein for matrix-cell inter-
action [37]. Through the RGD motif, osteopontin medi-
ates the attachment and activation of osteoclasts [38]
and can facilitate attachment of bone cells to minera-
lized tissue surfaces [39].
Conclusion
Our results generally suggest that adenoviral modifica-
tion of bone growth-associated cells by simultaneous
transduction with BMP-2 and IHH represents a pro-
mising way to stimulate osseous healing. Nevertheless,
these results must be confirmed by thorough in vivo
investigations.
Furthermore, viral transduction is eyed skeptically in
treating nonlethal conditions in humans [40].Adenoviruses are DNA viruses. Their genomes rarely
integrate into host-cell DNA. Nevertheless, transgene
expression by these viruses is congruent with the re-
quirements of healing bone. With adenoviruses, the cho-
sen recombinant vector can be produced at high titer.
Furthermore, adenovirus displays a high infectivity toward
many cell types [41].
Disadvantages of adenovirus certainly include its high
antigenicity [41], as many individuals possess circulating,
neutralizing antibodies. These antibodies might reduce
the effectiveness of adenovirus-based gene therapy.
Moreover, the caused inflammatory response may nega-
tively influence the healing process [42]. No consensus
exists concerning the most appropriate vectors and trans-
genes, and, consequently, further research is needed.
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